Antony C. Mattessich - 20 Aug 2021 Form 4 Insider Report for OCULAR THERAPEUTIX, INC (OCUL)

Role: President and CEO, Director
Signature: /s/ Donald Notman, Attorney-in-Fact for Antony C. Mattessich
Issuer symbol: OCUL
Transactions as of: 20 Aug 2021
Net transactions value: +$49,450
Form type: 4
Filing time: 24 Aug 2021, 08:49:25 UTC
Next filing: 29 Oct 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OCUL	Common Stock	Purchase	$49,450	+5,000	+5.1%	$9.89	102,900	20 Aug 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.88 to $9.89, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.88 to $9.89, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.